Tonix Pharmaceuticals Holding Corp Stock Nasdaq
Equities
US8902604094
Pharmaceuticals
Financials (USD)
Sales 2024 * | 17.3M | Sales 2025 * | 19.2M | Capitalization | 15.29M |
---|---|---|---|---|---|
Net income 2024 * | -75M | Net income 2025 * | -65M | EV / Sales 2024 * | 0.88 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 0.8 x |
P/E ratio 2024 * |
-0.17
x | P/E ratio 2025 * |
-0.15
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.99% |
1st Jan change | Capi. | |
---|---|---|
-4.66% | 87.53B | |
+1.32% | 40.42B | |
-18.95% | 29.48B | |
+57.86% | 25.43B | |
-17.69% | 11.49B | |
-43.00% | 11.3B | |
-9.14% | 11.1B | |
+5.24% | 8.75B | |
-8.42% | 7.99B |